Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuichiro Higo

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
World Journal of Stem Cells|April 3, 2023
Disease modeling of desmosome-related cardiomyopathy using induced pluripotent stem cell-derived cardiomyocytesShuichiro Higo
Methods in Molecular Biology (Clifton, N.J.)|July 24, 2021
Genome Editing in Human Induced Pluripotent Stem Cells (hiPSCs)Shuichiro Higo, Shungo Hikoso, Shigeru Miyagawa, et al.
Thrombosis and Haemostasis|April 27, 2012
Erythropoietin, progenitor cells and restenosis. A critique of Stein et alTetsuo Minamino, Ken Toba, Shuichiro Higo, et al.
American Heart Journal Plus : Cardiology Research and Practice|February 26, 2025
Protein C deficiency with recurrent systemic thrombosis associated with compound heterozygous <i>PROC</i> missense variantsMikio Shiba, Shuichiro Higo, Yu Morishita, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|October 1, 2005
Elevation of plasma matrix metalloproteinase-9 in the culprit coronary artery in patients with acute myocardial infarction: clinical evidence from distal protectionShuichiro Higo, Masaaki Uematsu, Masakazu Yamagishi, et al.
JACC. Case Reports|June 4, 2026
Transient Left Ventricular Dysfunction in Loeys-Dietz Syndrome With Loss-of-Function TGFBR1 VariantsYuna Hirota, Shuichiro Higo, Tomoka Tabata, et al.
Cardiovascular Drugs and Therapy|September 4, 2012
Design and rationale of low-dose erythropoietin in patients with ST-segment elevation myocardial infarction (EPO-AMI-II study): a randomized controlled clinical trialTetsuo Minamino, Ken Toba, Shuichiro Higo, et al.
Small (Weinheim an Der Bergstrasse, Germany)|February 12, 2025
Heart-on-a-Miniscope: A Miniaturized Solution for Electrophysiological Drug Screening in Cardiac OrganoidsPouria Tirgar, Abigail Vikstrom, José Miguel Romero Sepúlveda, et al.
Internal Medicine (Tokyo, Japan)|December 20, 2021
Phospholamban p.Arg14del Cardiomyopathy: A Japanese Case SeriesTomoka Tabata, Yuki Kuramoto, Tomohito Ohtani, et al.
Scientific Reports|July 20, 2021
Homogeneous 2D and 3D alignment of cardiomyocyte in dilated cardiomyopathy revealed by intravital heart imagingKiyoshi Masuyama, Tomoaki Higo, Jong-Kook Lee, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
World Journal of Stem Cells|April 3, 2023
Disease modeling of desmosome-related cardiomyopathy using induced pluripotent stem cell-derived cardiomyocytesShuichiro Higo
Methods in Molecular Biology (Clifton, N.J.)|July 24, 2021
Genome Editing in Human Induced Pluripotent Stem Cells (hiPSCs)Shuichiro Higo, Shungo Hikoso, Shigeru Miyagawa, et al.
Thrombosis and Haemostasis|April 27, 2012
Erythropoietin, progenitor cells and restenosis. A critique of Stein et alTetsuo Minamino, Ken Toba, Shuichiro Higo, et al.
American Heart Journal Plus : Cardiology Research and Practice|February 26, 2025
Protein C deficiency with recurrent systemic thrombosis associated with compound heterozygous <i>PROC</i> missense variantsMikio Shiba, Shuichiro Higo, Yu Morishita, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|October 1, 2005
Elevation of plasma matrix metalloproteinase-9 in the culprit coronary artery in patients with acute myocardial infarction: clinical evidence from distal protectionShuichiro Higo, Masaaki Uematsu, Masakazu Yamagishi, et al.
JACC. Case Reports|June 4, 2026
Transient Left Ventricular Dysfunction in Loeys-Dietz Syndrome With Loss-of-Function TGFBR1 VariantsYuna Hirota, Shuichiro Higo, Tomoka Tabata, et al.
Cardiovascular Drugs and Therapy|September 4, 2012
Design and rationale of low-dose erythropoietin in patients with ST-segment elevation myocardial infarction (EPO-AMI-II study): a randomized controlled clinical trialTetsuo Minamino, Ken Toba, Shuichiro Higo, et al.
Small (Weinheim an Der Bergstrasse, Germany)|February 12, 2025
Heart-on-a-Miniscope: A Miniaturized Solution for Electrophysiological Drug Screening in Cardiac OrganoidsPouria Tirgar, Abigail Vikstrom, José Miguel Romero Sepúlveda, et al.
Internal Medicine (Tokyo, Japan)|December 20, 2021
Phospholamban p.Arg14del Cardiomyopathy: A Japanese Case SeriesTomoka Tabata, Yuki Kuramoto, Tomohito Ohtani, et al.
Scientific Reports|July 20, 2021
Homogeneous 2D and 3D alignment of cardiomyocyte in dilated cardiomyopathy revealed by intravital heart imagingKiyoshi Masuyama, Tomoaki Higo, Jong-Kook Lee, et al.
Pageof 5